Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
about
Interferon-alpha for maintenance of follicular lymphomaInterferon-alpha for follicular lymphomaA randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphomaLymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy.Treatment of Waldenstrom's macroglobulinemia with very low doses of alpha interferon.Management of non-Hodgkin's lymphomas.Inroads in the therapy of indolent lymphomas: exploiting biological insights.Cytokine therapeutics: lessons from interferon alphaCpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myelomaHigh ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.Curative Effects for B-Cell Lymphoma Accomplished by Direct-Acting Antiviral Agents of Hepatitis C.Regrowth resistance in cancer: why has it been largely ignored?Non-Hodgkin's lymphoma in the older person: a review.Growth modulation of freshly isolated non-Hodgkin's B-lymphoma cells induced by various cytokines and all-trans-retinoic-acid.Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support.Bone marrow transplantation in low-grade non-Hodgkin's lymphoma.Low-grade lymphomas: new entities and treatment concepts.Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseases.Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma.Cost-Effectiveness of interferon alfa-2b added to chemotherapy for high-tumor-burden follicular non-Hodgkin's lymphoma.Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma.Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease.[IFN-alpha consolidation after intensive chemotherapy does not bring any survival advantage in low-grade non-Hodgkin lymphoma].Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691.Follicular lymphoma: a historical overview.
P2860
Q24240781-A3444D9C-778C-4B83-ACE5-71AFE300EA4CQ24247519-38D75DB8-F63D-47DA-8B5C-1DF44D9696E7Q28343471-8B339B33-387F-4E17-9160-E49CDCE35078Q33427078-2FB1161E-B422-49A9-906D-9C19E2233E2CQ33495057-9E982772-8D0E-4F2F-B9EE-D05CFDF8404AQ33682014-03173486-E0E9-452B-8E4B-E7940730E879Q34040863-FB9C3F57-7DE6-469B-9C9F-02B222613F76Q35033232-9735BAF0-3C2A-417C-9BAE-1FE42333A0C2Q37260574-E6EC316E-ED8B-4719-A842-18442552B5B3Q40063998-F33666A8-A917-4636-96E4-900802D501B8Q40206630-30B9931D-1D49-42B9-BC62-659C44AF2C96Q40455407-B8B812AA-58A7-4025-A787-C48274B89759Q40491800-80FCFEA6-7AA3-49BD-B256-5E5032806053Q40902026-06776EB3-7373-494A-BA61-08BC7DA6B32DQ40918017-470DE5CC-543C-4D88-8D12-AF09FFCA9221Q40958067-49750DD6-D717-49D6-A9BD-0D59D43312D7Q40972935-EC9A2934-9423-4C39-A2CE-A26DBEF69E1BQ41552434-45DCE2EF-749E-4056-816F-24F73804FC86Q43135381-3CA274CF-0DA4-4A41-8E36-05FBC479A86BQ43653707-7CC03801-FFDB-4377-AE59-671F190CAAE8Q43653725-22184D64-7761-48BF-8BFE-6DC74385A126Q44455716-4392837E-A831-48A7-AFA3-308B715A84C4Q44855477-B7CF1A29-A7C9-4A7E-B7A8-06A10944B520Q49479885-0A170199-68B9-4A6E-BE1C-DC7E3091103DQ53203748-6FC3B7D9-4D3D-46C2-9BD9-BDE8175299D5
P2860
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@ast
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@en
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@nl
type
label
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@ast
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@en
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@nl
prefLabel
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@ast
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@en
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@nl
P2093
P1476
Interferon alfa combined with ...... s with non-Hodgkin's lymphoma.
@en
P2093
Andersen JW
Hawkins MJ
O'Connell MJ
Smalley RV
P304
P356
10.1056/NEJM199211053271902
P407
P577
1992-11-01T00:00:00Z